Key result
Immunosuppression, antiarrhythmics, and an ICD successfully control AF and VT in cardiac sarcoidosis.
Why the study?
Cardiac sarcoidosis can cause complex atrial and ventricular arrhythmias and its management is challenging due to multisystem involvement and treatment complexity.
Case Report (n=1)
No
This case highlights the complexity of diagnosing and managing atrial and ventricular arrhythmias in patients with cardiac sarcoidosis.
Advanced imaging may refine CS evaluation; leaves open optimal immunosuppression and device strategies in arrhythmias.
Cardiac sarcoidosis (CS) can cause atrial and ventricular arrhythmias, conduction system disease, and congestive heart failure. The use of advanced imaging modalities including cardiac magnetic resonance and positron emission tomography with 2-deoxy-2-[fluorine-18]fluoro-D-glucose can be helpful in evaluating the extent of disease and response to treatment. The management of CS patients can be challenging, requiring immunosuppression medications, antiarrhythmic drugs, implantable cardiac devices, and cardiac ablation procedures. We report a patient with CS initially presenting with paroxysmal atrial fibrillation who later developed polymorphic ventricular tachycardia, highlighting the complexity of diagnosis and management in patients with multisystem sarcoidosis.
No takes yet. Share an insight, caveat, or question.
Lau et al. (2018) conducted a case report in Cardiac sarcoidosis (n=1). Multidisciplinary management (immunosuppression, antiarrhythmics, ICD) was evaluated. A 55-year-old male with cardiac sarcoidosis presenting with atrial fibrillation and later ventricular tachycardia was successfully managed with immunosuppression, antiarrhythmic therapy, and an ICD.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: